healthy volunteers and niddm patients ingested a standard low-carbohydrate breakfast , and glibenclamide was administered 110-120 min later either as an intravenous bolus ( 12.5 micrograms/kg body wt ) , or as a tablet ( 5 mg hb 419 ) .
C0011860
niddm
C0017628
glibenclamide